Amidst uncertainties around Older Americans Act reauthorization and turmoil at the Administration for Community Living, the nation’s aging network and advocates are trying to sustain the ...
California cannot control whether mifepristone will remain available at the national level. But it can control whether Medi-Cal managed care plans can connect patients to providers and verified ...
Foreign reference pricing frameworks often differ from the way the US has historically valued medical innovation. A more ...
The proposed changes are relatively modest, yet they represent an important procedural step forward in the implementation of ...
Congress should require the FDA to make DSCSA traceability data accessible and interpretable not only by regulatory agencies ...
Rather than impose one-size-fits-all solutions, federal and state policy makers should craft Medicaid payment policies that ...
The CMS actuaries are—understandably and reasonably—cautious. But recent developments indicate that changes in technology and policy may alter health care delivery and spending—and consequently our ...
Nasal naloxone remains expensive relative to the cost of the underlying drug and continues to strain budgets of public health ...
If an HHS Secretary can seek to unilaterally overturn an evidence-based standard of transgender health care, the same can ...
Having been stymied by courts elsewhere. the Justice Department has turned to a conservative federal district court in Texas ...
Similar to opioids and intoxicating hemp-derived THC products, a well-funded and growing kratom industry with lobbying power ...
The finding that Medicaid work requirements could reduce poverty by 1.6 to 2.9 million people, rather than representing their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results